VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors

All categories
DBCAT005731Pharmacologic class

A DrugBank category of 2 drugs. 2 of them are approved.

Drugs

What you can answer from here — as of August 31, 2022

2DrugsEach linked to its full drug card
Listed above
10Drug targetsEvery drug–target pair in the class, with bond type
Sign in
157Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
4Routes of administrationHow the drugs in this class are given
Sign in

Which targets do VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In